World Infectious Disease Molecular Diagnostics Market Report 2021: Forecasts, Strategies and Trends by Syndrome…

first_img Pinterest Abbott DiagnosticsAccelerate DiagnosticsAdor DiagnosticsAkonni BiosystemsAlveo TechnologiesApplied BioCodeAtlas GeneticsAus DiagnosticsBD DiagnosticsBeckman CoulterBiocartisbioMerieuxBio-Rad LaboratoriesBosch Healthcare Solutions GmbHCepheidChembioCuretisDiagenodeDiagnosticsDiaSorinEiken ChemicalFusion GenomicsGenedriveGenePOC DiagnosticsGenMark DxGrifolsHologicIlluminaInflammatixJanssen DiagnosticsKariusLexageneLuminexMbio DiagnosticsMeridian BioscienceMesa BiotechMobidiagNanomixOxford Nanopore TechnologiesPanagenePrimerdesignProminexQiagenQuantumdxQuidelRoche Molecular DiagnosticsSeegeneSiemens HealthineersT2 BiosystemsThermo FisherVeramarxXCR Diagnostics For more information about this report visit https://www.researchandmarkets.com/r/z5rqaf View source version on businesswire.com:https://www.businesswire.com/news/home/20210203005428/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/03/2021 05:51 AM/DISC: 02/03/2021 05:51 AM http://www.businesswire.com/news/home/20210203005428/en By Digital AIM Web Support – February 3, 2021 Facebook Profiles of Key MDx Companies WhatsApp Twitter World Infectious Disease Molecular Diagnostics Market Report 2021: Forecasts, Strategies and Trends by Syndrome with Multiplex and Point of Care Market Analysis – ResearchAndMarkets.com Pinterestcenter_img Previous articleGlobal Liquid Biopsy Markets Report 2021: Analysis & Forecasts to 2025 – Screening, Diagnosis, Therapy Selection and Recurrence Monitoring – ResearchAndMarkets.comNext article$47.14 Billion Medical Spa Services Market – Global Opportunity Analysis and Industry Forecast, 2020 – 2030 – ResearchAndMarkets.com Digital AIM Web Support Twitter TAGS  WhatsApp DUBLIN–(BUSINESS WIRE)–Feb 3, 2021– The “Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and Customization 2020 to 2024” report has been added to ResearchAndMarkets.com’s offering. Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear. The Molecular Diagnostics – Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance. Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Exciting technical developments especially in the seesaw between sequencing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations. Trends like:Multiplex testingEmerging economies and global prosperityBiotechnology advances in geneticsPathogen evolutionClimate changeGlobalizationThe rise of rapid testing Market Trends Factors Driving GrowthNew Genotypes Creating New MarketsAging Population a Boon for All DiagnosticsDeveloping World Driving ID Dx GrowthPoint of Care – Why Centralization is Losing SteamSelf TestingThe Need for Speed Factors Limiting GrowthLower CostsInfectious Disease is DecliningWellness HurtsEconomic Growth improves Living Standards Instrumentation and AutomationInstruments Key to Market ShareThe Shrinking Machine.Multiplex, Point of Care and The Speed Factor Diagnostic Technology DevelopmentThe Sepsis Testing Market – A New Direction?POCT/Self Testing as a Disruptive ForceThe Genetics Play – One Test for All Known InfectionsAntibiotic Resistance Genes – Simplifying Diagnostics Infectious Disease Recent DevelopmentsRecent Developments- Importance and How to Use This SectionImportance of These DevelopmentsHow to Use This SectionFusion Genomics to Assess NGS-Based Respiratory Tract Infection AssayNew Genomic Tests Diagnose Deadly Infections FasterBiotia Raises $2.4M Seed RoundSTDs resurge in USAres Genetics signs R&D agreement with leading global IVD corporationCell-Free DNA Used for Infectious Disease TestingOne BioMed Raises $5MFDA grants Qiagen clearance for syndromic testing systemiCubate, Wondfo Biotech Form Chinese JV to Develop MDx AssaysResearchers Launch CRISPR Dx Firm Sherlock BiosciencesIsrael’s BATM to Invest up to $30M in Ador DiagnosticsSuperbug Test from Mobidiag Gets CE MarkAkonni Biosystems Submits Multiplex Diagnostics System to FDAMesa Biotech RSV Test Wins CE MarkKarius Test to Be Available in BrazilPanagene’s STD kit gains ApprovalStartup Prominex Raises $4M in Series AGenePOC’s Investment Validated by Medicare DecisionGenePOC launches its GenePOC CDiff test in CanadaNYU researchers adapt HIV test to Zika virusGA-EMS receives diagnostic device contractBiocartis & Immunexpress Sign Partnership for SepsisPerkinElmer to Acquire Euroimmun for $1.3BAlveo Closes Financing to Create Accessible Diagnostics DevicesSiemens Healthineers completes takeover of Fast Track DiagnosticsSekisui Diagnostics Enters Strategic Alliance with Mesa Biotech IncChembio and FIND to Develop Point-of-Care Multiplex TestLocus Biosciences and IDbyDNA Partner to Develop Companion Diagnostic TestAlere bags FDA nod for rapid flu diagnosticFDA approves tests of tick-borne disease to protect blood supplyQiagen Trichomonas Assay Gets CE MarkVela Diagnostics HSV Test Gets FDA ClearanceQIAGEN enters into an agreement to acquire STAT-DxBruker to Acquire Majority Stake in Infectious Disease MDx Firm HainApplied BioCode’s Syndromic Gastrointestinal Pathogen Panel Approved by the FDAAres Genetics to develop AI diagnostic test for infectious diseasesFDA Considers Guidelines for NGS-Based Infectious Disease Diagnostics Local NewsBusiness Facebooklast_img

Write a Reply or Comment

Your email address will not be published.


You may use these HTMLtags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>